Three cheers to the private sector
This Bloomberg story on Glaxo, Avandia (diabetes drug) and the risk of heart attack it causes, whether Glaxo was aware, informed patients, physicians, etc. has an all-too-familiar and depressing ring to it. GSK’s explanation on its web site appears convincing until you read this piece in NYT and the last lines:
In 1999, for instance, Dr. [...]

Recent Comments